FONAR Corporation
$18.8
▲
0.05%
2026-04-21 06:54:02
www.fonar.com
NCM: FONR
Explore FONAR Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$117.93 M
Current Price
$18.8
52W High / Low
$18.86 / $12
Stock P/E
15.61
Book Value
$27.01
Dividend Yield
—
ROCE
5.81%
ROE
6.01%
Face Value
—
EPS
$1.15
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
535
Beta
0.99
Debt / Equity
24.44
Current Ratio
10
Quick Ratio
8.28
Forward P/E
—
Price / Sales
1.11
Enterprise Value
$95.09 M
EV / EBITDA
6.32
EV / Revenue
0.9
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Insight Molecular Diagnostics Inc. | $3.99 | — | $128.35 M | — | -223.51% | 229.65% | $8.51 / $2.33 | $-1.1 |
| 2. | Veracyte, Inc. | $33.45 | 39.66 | $2.63 B | — | 5.82% | 5.34% | $50.71 / $22.61 | $16.5 |
| 3. | CareDx, Inc. | $21.29 | — | $1.11 B | — | -7.75% | -6.27% | $23.24 / $10.96 | $5.95 |
| 4. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
| 5. | Check-Cap Ltd. | $1.9 | — | $13.56 M | — | 659.83% | -1.3% | $3.92 / $0.59 | $0.64 |
| 6. | Thermo Fisher Scientific Inc. | $521.21 | 29.42 | $194.29 B | 0.36% | 8.52% | 13.02% | $643.99 / $385.46 | $141.96 |
| 7. | Castle Biosciences, Inc. | $25.16 | — | $744.77 M | — | -8.4% | -5.21% | $44.28 / $14.59 | $15.86 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 25.55 M | 26.04 M | 27.28 M | 27.16 M | 24.95 M | — |
| Operating Profit | 3 M | 3.19 M | 0.89 M | 3.66 M | 2.44 M | — |
| Net Profit | 2.06 M | 2.26 M | 0.73 M | 2.51 M | 1.96 M | — |
| EPS in Rs | 0.33 | 0.37 | 0.12 | 0.41 | 0.32 | 0.46 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 104.35 M | 102.88 M | 98.65 M | 97.59 M |
| Operating Profit | 11.6 M | 16.54 M | 14.79 M | 22.01 M |
| Net Profit | 8.33 M | 10.57 M | 9.38 M | 12.44 M |
| EPS in Rs | 1.35 | 1.71 | 1.52 | 2.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 216.91 M | 214.25 M | 200.58 M | 199.34 M |
| Total Liabilities | 56.8 M | 57.46 M | 49.75 M | 53.11 M |
| Equity | 172.61 M | 165.97 M | 157.91 M | 150.29 M |
| Current Assets | 144.67 M | 140.32 M | 125.66 M | 118.69 M |
| Current Liabilities | 17.12 M | 17.86 M | 15.62 M | 16.75 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 11.26 M | 14.09 M | 14.47 M | 15.3 M |
| Investing CF | -3.8 M | -0.85 M | -4.34 M | -5.18 M |
| Financing CF | -7.47 M | -8.18 M | -7.57 M | -5.86 M |
| Free CF | 7.45 M | 13.27 M | 10.13 M | 10.67 M |
| Capex | -3.82 M | -0.82 M | -4.34 M | -4.63 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 1.43% | 4.3% | 1.08% | — |
| Earnings Growth % | -21.13% | 12.71% | -24.64% | — |
| Profit Margin % | 7.99% | 10.27% | 9.5% | 12.75% |
| Operating Margin % | 11.12% | 16.07% | 14.99% | 22.55% |
| Gross Margin % | 41.12% | 43.87% | 46.38% | 48.17% |
| EBITDA Margin % | 17.73% | 23.27% | 24.95% | 32.43% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.